Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis
Clinical trial NCT04315480 · UNKNOWN
Trial details
- NCT number
- NCT04315480
- Sponsor
- Università Politecnica delle Marche
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-12
- Primary completion
- 2020-04-09
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.